SCHEMBL19981483

SCHEMBL19981483

CCOP(C)(=O)N1CCC([N+]2(C)CCCC2)CC1

nearest known ligand 0.35

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
EBP Q15125 1/20 0.35
DHCR7 Q9UBM7 1/20 0.35
L3MBTL3 Q96JM7 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15443876 0.74 GNAI3 (0.33)
SCHEMBL14654986 0.73 MAPK1 (0.41) L3MBTL3L3MBTL1
SCHEMBL14655015 0.72 MAPK1 (0.43) L3MBTL3L3MBTL1
SCHEMBL409857 0.71 EBP (0.33) EBPDHCR7L3MBTL3L3MBTL1
SCHEMBL14655002 0.71 TSHR (0.31)
SCHEMBL15443877 0.71 L3MBTL3 (0.33) L3MBTL3
SCHEMBL15443892 0.70 TSHR (0.30)
SCHEMBL15443900 0.70 ACHE (0.33)
SCHEMBL15443918 0.69 MMP1 (0.31)
SCHEMBL15443801 0.68 TSHR (0.37)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2788487-B1 OLIGONUCLEOTIDE ANALOGUES TARGETING HUMAN LMNA SAREPTA THERAPEUTICS INC (US) 2018-04-04 EP disclosed
EP-2788488-B1 METHODS FOR TREATING PROGEROID LAMINOPATHIES USING OLIGONUCLEOTIDE ANALOGUES TARGETING HUMAN LMNA SAREPTA THERAPEUTICS INC (US) 2018-03-21 EP disclosed